← Eichor
Condition: Hiv Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hiv Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
NA · 1 location(s) · University of Miami · NCT06062342An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
NA · 1 location(s) · University of Miami · NCT03738410The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
Phase N/A · 1 location(s) · University of California, San Francisco · NCT01202305Intervention to Improve Parent Communication About Sexuality
NA · 1 location(s) · University of Pennsylvania · NCT07672067Upper Gastrointestinal Endoscopy in HIV-infected Individuals
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Saint Pierre · NCT07425067Thailand HIV and Stigma Reduction Study
NA · 3 location(s) · University of Massachusetts, Worcester · NCT06576648Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!
NA · 1 location(s) · University of Washington · NCT06745050High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
NA · 1 location(s) · University of Alabama at Birmingham · NCT05965518Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06819176Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02154035Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06441123Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i
Phase 1 · 7 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07390474One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care Project
NA · 1 location(s) · University of Washington · NCT05905640Testing a Gender-inclusive HIV Prevention Program
NA · 1 location(s) · Center for Innovative Public Health Research · NCT06586151Prevention ICONA Dedicated Ensemble
Phase N/A · 53 location(s) · Fondazione ICONA · NCT07186244Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Phase 1/Phase 2 · 2 location(s) · University of Melbourne · NCT05187429REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Phase 4 · 10 location(s) · CAN Community Health · NCT07476339Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch
Phase 3 · 3 location(s) · Chelsea and Westminster NHS Foundation Trust · NCT04892654Improving Engagement in HIV and Cancer Care in Zimbabwe
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT06934369Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT06691321Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Phase 2/Phase 3 · 6 location(s) · Johns Hopkins University · NCT06568484A Pilot Study of an Online HIV Stigma Training for Nursing Students in Iran
NA · 1 location(s) · University of California, San Francisco · NCT06509113Augmented Renal Clearance in Neurocritical Care
Phase N/A · 3 location(s) · University of Alberta · NCT07410624An Effectiveness Trial of the PrEP for WINGS Study
NA · 1 location(s) · Columbia University · NCT06853314Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.
Phase 3 · 4 location(s) · ANRS, Emerging Infectious Diseases · NCT05813964Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells an
Phase 1 · 2 location(s) · Thomas Aagaard Rasmussen · NCT07481175Enhancing Smoking Cessation for African American People Everywhere
Phase 2 · 1 location(s) · University of Houston · NCT07024992reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
NA · 1 location(s) · University of Miami · NCT05958017INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
NA · 1 location(s) · RAND · NCT06949774Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Phase N/A · 21 location(s) · Radboud University Medical Center · NCT00825929
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.